Clinical Trials Browser

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04660929 2024-12-18

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Carcinoma, Ovarian Epithelial, Adenocarcinoma, Bile Duct Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Small Cell, Carcinoma, Ductal, Small Cell Lung Carcinoma, Inflammatory Breast Neoplasms

Clinical Trials

OUTREACH

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

A Study of HY-0102 in Patients With Advanced Solid Tumors

U87 CART in Treatment of Advanced Solid Tumor

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307

MK-3475-E90

PREDICT

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas

A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

PITHAC

Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

IMC001 for Clinical Research on Advanced Digestive System Malignancies

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor

A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.

Longitudinal Immune-phenotyping of HCC Following MK-3475

A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer

Notable-HCC

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma

Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions

CCGLC-003

CCGLC-007

To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG)

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

EpCAM CAR-T for Treatment of Advanced Solid Tumors

RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer

Minnelide 101

Minnelide™ Capsules Alone and in Combination With Paclitaxel in Advanced Gastric Cancer

NWRD06 DNA Plasmid for HCC After Radical Resection

CISPD-5

A Study of YL-17231 in Patients With Advanced Solid Tumors

Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer

Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma

CAT_PB

NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection

3D Printed Models for Liver Surgery

Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors

XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell Carcinoma